MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.

作者: Javier Beaumont , Begoña López , Susana Ravassa , Nerea Hermida , Gorka San José

DOI: 10.1038/SREP40696

关键词: Heart failureInternal medicineFibrosisAortic valve stenosisMedicineCollagen networkCardiologyConnective tissueStenosisLysyl oxidaseBiomarker (medicine)

摘要: This study analyzed the potential associations of 7 myocardial fibrosis-related microRNAs with quality collagen network (e.g., degree fibril cross-linking or CCL) and enzyme lysyl oxidase (LOX) responsible for CCL in 28 patients severe aortic stenosis (AS) whom 46% had a diagnosis chronic heart failure (HF). MicroRNA expression was blood samples. From studied only miR-19b presented direct correlation (p < 0.05) between serum myocardium. Compared to controls both were reduced (p < 0.01) AS patients. In addition, myocardium HF compared without HF. Myocardial inversely correlated LOX, LV stiffness vitro studies inhibition increased connective tissue growth factor protein LOX human fibroblasts. conclusion, decreased may be involved up-regulation excessive CCL, consequently patients, namely those Serum can biomarker these alterations particularly

参考文章(46)
Marc R. Dweck, Nicholas A. Boon, David E. Newby, Calcific Aortic Stenosis: A Disease of the Valve and the Myocardium Journal of the American College of Cardiology. ,vol. 60, pp. 1854- 1863 ,(2012) , 10.1016/J.JACC.2012.02.093
Johann Bauersachs, Regulation of myocardial fibrosis by MicroRNAs. Journal of Cardiovascular Pharmacology. ,vol. 56, pp. 454- 459 ,(2010) , 10.1097/FJC.0B013E3181EE81DF
Ioannis Karakikes, Antoine H. Chaanine, Soojeong Kang, Bertrand N. Mukete, Dongtak Jeong, Shihong Zhang, Roger J. Hajjar, Djamel Lebeche, Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling Journal of the American Heart Association. ,vol. 2, ,(2013) , 10.1161/JAHA.113.000078
Andrea Tanzer, Peter F Stadler, Molecular Evolution of a MicroRNA Cluster Journal of Molecular Biology. ,vol. 339, pp. 327- 335 ,(2004) , 10.1016/J.JMB.2004.03.065
A. Bonauer, G. Carmona, M. Iwasaki, M. Mione, M. Koyanagi, A. Fischer, J. Burchfield, H. Fox, C. Doebele, K. Ohtani, E. Chavakis, M. Potente, M. Tjwa, C. Urbich, A. M. Zeiher, S. Dimmeler, MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice Science. ,vol. 324, pp. 1710- 1713 ,(2009) , 10.1126/SCIENCE.1174381
Aldo Domenico Milano, Giuseppe Faggian, Mikhail Dodonov, Giorgio Golia, Anna Tomezzoli, Uberto Bortolotti, Alessandro Mazzucco, Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 144, pp. 830- 837 ,(2012) , 10.1016/J.JTCVS.2011.11.024
Duaa Dakhlallah, Kara Batte, Yijie Wang, Carmen Z. Cantemir-Stone, Pearlly Yan, Gerard Nuovo, Adel Mikhail, Charles L. Hitchcock, Valerie P. Wright, S. Patrick Nana-Sinkam, Melissa G. Piper, Clay B. Marsh, Epigenetic Regulation of miR-17∼92 Contributes to the Pathogenesis of Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine. ,vol. 187, pp. 397- 405 ,(2013) , 10.1164/RCCM.201205-0888OC
H P Krayenbuehl, O M Hess, E S Monrad, J Schneider, G Mall, M Turina, Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. ,vol. 79, pp. 744- 755 ,(1989) , 10.1161/01.CIR.79.4.744
Ana V. Villar, Raquel García, David Merino, Miguel Llano, Manuel Cobo, Cecilia Montalvo, Rafael Martín-Durán, María A. Hurlé, J. Francisco Nistal, Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients International Journal of Cardiology. ,vol. 167, pp. 2875- 2881 ,(2013) , 10.1016/J.IJCARD.2012.07.021
Zhenwei Pan, Xuelin Sun, Hongli Shan, Ning Wang, Jinghao Wang, Jinshuai Ren, Shuya Feng, Liangjun Xie, Chunying Lu, Ye Yuan, Yang Zhang, Ying Wang, Yanjie Lu, Baofeng Yang, MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway Circulation. ,vol. 126, pp. 840- 850 ,(2012) , 10.1161/CIRCULATIONAHA.112.094524